Abstract

Addition of nivolumab to chemotherapy in patients with advanced gastric cancer: a relevant step ahead, but still many questions to answer

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Pembrolizumab (pembro) versus standard of care chemotherapy (chemo) in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062.
Kensei Yamaguchi ... Jeeyun Lee
Journal of Clinical Oncology | VOL. 38
Kensei Yamaguchi, et. al.Kensei Yamaguchi ... Jeeyun Lee
20 May 2020
Abstract LB-258: Efficacy of first-line (1L) pembrolizumab by PD-L1 combined positive score <1, 1-19, and ≥20 in recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): KEYNOTE-048 subgroup analysis
Denis Soulières ... Prakash Neupane
Cancer Research | VOL. 80
Denis Soulières, et. al.Denis Soulières ... Prakash Neupane
13 Aug 2020
How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy
A Fundytus ... C.M Booth
Annals of Oncology | VOL. 32
A Fundytus, et. al.A Fundytus ... C.M Booth
08 Apr 2021
The utility of PD-L1 as a prognostic marker in pancreatic ductal adenocarcinoma (PDAC).
Nagma Shah ... Linda Wu
Journal of Clinical Oncology | VOL. 41
Nagma Shah, et. al.Nagma Shah ... Linda Wu
01 Feb 2023
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
Perception of cure in prostate cancer: human-led and artificial intelligence-assisted landscape review and linguistic analysis of literature, social media and policy documents
Ruhee Jain ... Francesco De Solda
ESMO Open | VOL. 9
Ruhee Jain, et. al.Ruhee Jain ... Francesco De Solda
13 May 2024
Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial
Adrienne M Gilligan ... Luis E Raez
ESMO Open | VOL. 9
Adrienne M Gilligan, et. al.Adrienne M Gilligan ... Luis E Raez
01 May 2024
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study
Natalie Prinzi ... Sandra P D’Angelo
ESMO Open | VOL. 9
Natalie Prinzi, et. al.Natalie Prinzi ... Sandra P D’Angelo
01 May 2024
Treatment and survival of patients diagnosed with high-risk HR+/HER2− breast cancer in the Netherlands: a population-based retrospective cohort study
S.M.E Geurts ... K.B.M.I Keymeulen
ESMO Open | VOL. 9
S.M.E Geurts, et. al.S.M.E Geurts ... K.B.M.I Keymeulen
01 May 2024
View more papers